Marvin L. White - 28 Jan 2024 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role: President and CEO, Director
Signature: /s/ SoYoung Kwon, Attorney-In -Fact
Issuer symbol: APVO
Transactions as of: 28 Jan 2024
Net transactions value: $0
Form type: 4
Filing time: 30 Jan 2024, 18:02:50 UTC
Previous filing: 30 May 2023
Next filing: 05 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	APVO	Common Stock	Options Exercise		+4,792	+12%		44,929	28 Jan 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	APVO	Restricted Stock Unit	Options Exercise	$0	-4,792	-100%	$0.000000^*	0	28 Jan 2024	Common Stock	4,792		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2	On January 29, 2021, the reporting person was granted 14,375 RSUs, vesting in three approximately equal annual installments beginning on January 28, 2022.